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Introduction
The physiochemical properties of a drug can influence the choice of dosage form in which it is delivered. Properties such as stability, pK a , partition coefficient and salt forms are all taken into consideration during pre-formulation studies [1] . In addition, it is important to assess the aqueous solubility, dissolution rate and intestinal permeability of a drug. These three factors have been used to classify drugs in the Biopharmaceutical Classification System (BCS) into four different classes [2] . BCS class II drugs are characterized by high membrane permeability but low aqueous solubility therefore; there is a low drug concentration gradient between the gut and the blood vessels limiting drug transport and oral bioavailability. The poor solubility of drugs has always been a major problem in pharmaceutical development and this problem is now more prevalent with more than 40 % of the new chemical entities being practically insoluble in water or lipophilic in nature [3] [4] [5] [6] [7] . As dissolution rates are typically the rate-limiting step for bioavailability, especially for poorly soluble drugs, enhancement of solubility is vital to attaining suitable systemic concentrations for therapeutic effect [8] .
Despite the recent advances in particle engineering, one of the most common method employed to aid the improvement of the dissolution rate of poorly soluble drugs is particle size reduction using high shear milling methods [9, 10] . This enhancement of dissolution rate by size reduction is due to the fact that solubility of drugs in intrinsically related to particle size of the drug [7] . As the particle size of the drug is reduced, the surface area available for solvation also increases. Particle size reduction is a safe method of increasing drug dissolution without altering the chemical nature of the drug. However, although particle size reduction leads to an increase in the effective surface area of the drug available to interact with the solvent, it does not increase equilibrium solubility of the drug [11] unless the size of particles are reduced to below 1 micrometre [12] . In addition, micronization may cause agglomeration and thus may negatively impact on the solubility and bioavailability during the storage of the final product [13] . Moreover, milled particles usually exhibit a high level of electrostatic charge; such high level of charge can increase the inter-particle cohesive forces leading to poor product performance [14] [15] [16] .
Other methods used to improve drug solubility include complexation [17] , liquisolid techniques [18, 19] and salt formation [20, 21] . Several authors have classed the solid dispersion approach as one of the most effective method of improving dissolution of drugs [5, 8, 22] . It involves the dispersion of one or more active ingredients in an inert excipient or carrier, where the active ingredients could exist in a finely crystalline, solubilised or amorphous state [23, 24] . Solid dispersion also enhances the absorption and efficacy of drugs in a dosage form, despite limitations such as cost, scale up and physicochemical instabilities of the dispersions under normal storage conditions [25] [26] [27] . Al-Hamidi and co-workers have studied the rate of carbamazepine (CBZ), ibuprofen (IBU) and PXM (PXM) in solvent evaporated and co-ground solid dispersions [3, 22, 28, 29] . Asare-Addo et al [8] , also studied the effect of GLU on indomethacin (IND) dissolution and charging properties using a solvent evaporation process. All these authors showed that incorporation of GLU in PXM, IBU, CBZ and IND using either the solvent evaporation or grinding method significantly increased the dissolution rates of these drugs. They attributed the increased solubility and dissolution rate of drugs observed to be due to particle size reduction to sub-micron levels, change in polymorphic forms and the improved wettability of the drug particle by the dissolved hydrophilic carrier [28, 30] .
PXM (4-hydroxy-2-methyl-N-(2-piridyl) 2H-1,2-benzothiazine-3-carboxamide-1, 1-dioxide) is one of the most potent non-steroidal anti-inflammatory and analgesic drugs used in treatment of various acute and chronic musculoskeletal and joint disorders [31] . This drug was used as the model BCS class II drug. In addition, GLU was the preferred hydrophilic carrier due to its popular use as a nutritional supplement for humans in decreasing pain and improving mobility in osteoarthritic joints of humans when administered orally [32, 33] . The limited solubility of PXM leads to a delayed onset of therapeutic effect. Oral absorption is slow and gradual with maximum absorption occurring 3 -5 hours after administration and a long half-life of elimination [34] .
Spray drying of poorly soluble drugs could potentially enhance their solubility [35] . The state of the final spray dried product depends on the nature of the drug as the process may result in the amorphous, partially crystalline, metastable crystal forms [36] . The ability of a pure drug substance to convert into its amorphous form during spray drying depends mainly on its inherent glass forming ability and crystallization tendency [37] and to a lesser extent on the preparation methods [38, 39] . In the amorphous state, the drug exhibits high levels of super-saturation in aqueous media compared to the crystalline drug, thereby achieving higher apparent solubility [40] . Spray drying works by providing a large surface area where heat transfer and atomization of the solution or suspension into small droplets can occur. It is also good at producing a uniform product that is spherical in shape [41] . By spraying the substance into a steam of hot air, the droplet will dry to form individual solid particles at a fast drying rate within milliseconds to a few seconds as a result of the high surface to volume ratio, which prevents phase separation between the drug and polymer components [42] .
In pharmaceutical development field, characterization of the electrostatic properties of powders has become a subject of extensive research [43] . Electrostatic charging within powders is generated from inter-particulate contacts and collisions (particle-particle and particle-surface collisions) in a gaseous environment; i.e. two different materials brought to contact and then separated [44] . To date, there are no pharmacopoeial methods for charge characterization [45] . Although bipolar charging commonly takes place in industrial processes of pharmaceutical particulates [46] , the most prevalent assessment of tribocharging is gained from the Faraday pail method, which provides only limited information in the form of net charge-to-mass ratio [47] . In this work, a novel instrument recently developed in the Wolfson Centre [48] (Figure 1a ) to characterise the charge properties of the particulate materials under investigation in the form of charge distribution is used. The major advantages of this method of charge sensing include its high sensitivity (charges on the particles equal or more than to 30×10 -15 C are detectable), quick measurement (< 1 min) and the lack of the particle flow disturbance. Kaialy et al. [16] applied the latter method to characterize the charge distribution of several size fractions of spray dried mannitol. In this study, the efficiency of the spray drying process in enhancing the dissolution rate of the PXM using GLU as a hydrophilic carrier is investigated. Recently, Adebisi et al (2016) [49] , also utilized this methodology in determining the charge distribution in co-ground solid dispersions. The charging propensity of the solid dispersions produced as a result of the spray drying process is also assessed to determine its effect on the handling of these dispersions. To the best of our knowledge, there is no reported work that has investigated the use of GLU in spray dried solid dispersions and the charge distributions from resulting samples.
Materials and Methods

Materials
PXM was purchased from TCI Chemicals (Japan). GLU was purchased from Sigma-Aldrich (UK).
The solvent used (acetone) was obtained from Fischer Scientific (UK) was of analytical grade and was used as obtained. The dissolution medium (pH 1.2) was prepared according to the USP 2003 method using the following materials: KCl (Sigma, UK) and concentrated HCl (Fisher, UK).
Preparation of PXM-GLU physical mixtures
Physical mixtures (PM) of PXM were prepared by mixing PXM and GLU in a Turbula ® blender (Type T2 C, Switzerland) for 10 min. Different PXM:GLU ratios (2:1, 1:1 and 1:2) were prepared for comparison. The powders were stored in screw-capped glass vials in a desiccator at room temperature until required after the mixing process.
Preparation of spray dried solid dispersions of drug-carrier
The spray drier (SD-06AG laboratory spray dryer, LabPlant UK) was set up in a closed mode configuration with an inlet temperature of 70 °C, a feed flow rate set to 10 mL min -1 and a nozzle size of 0.5 mm. Suspensions of PXM and GLU were made at three different drug:carrier ratios: 1:1 (Sample A) 1:2 (Sample B) and 2:1 (Sample C). When making the 1:1 ratio, 1.5 g of PXM was dissolved in a beaker containing 600 mL of acetone whereas 1.5 g of GLU was dissolved in a beaker containing 600 mL of deionised water under stirring conditions. The two solutions were then mixed together to form sample A. In the case of the 1:2 ratios, 1.5 g of PXM was dissolved in a beaker containing 600 mL of acetone and 3 g of GLU was also dissolved in a beaker containing 600 mL of deionised water. The two solutions were mixed together and that constituted sample B. For the 2:1 ratio, 3 g of PXM was dissolved in a beaker containing 600 mL of acetone and 1.5 g of GLU was also dissolved in a beaker containing 600 mL of deionised water. The two solutions were mixed together to form sample C. PXM (1.5 g PXM dissolved in 600 mL acetone) and GLU (1.5 g GLU dissolved in 600 mL deionised water) were also spray-dried separately as control samples.
The suspensions were under constant stirring (200 rpm) throughout the feeding process into the spray dryer to ensure uniformity. The solid dispersions obtained were stored in a desiccator until required.
Particle Size Analysis (PSD)
A Sympatec laser diffraction particle size analyser (Clausthal-Zellerfeld, Germany) was used for the determination of the particle size distribution of the spray-dried formulations. The mean particle size (D 10% , D 50% and D 90% ) was calculated automatically using the software provided. The procedure was as follows: about 2-3 g of each sample was transferred into the funnel of the VIBRI (vibrator feeder). The sample container was cautiously tapped against the funnel to ensure all the content was transferred. A test reference measurement was performed with the HELOS sensor using WINDOX software followed by a standard measurement. In this technique a laser beam is passed through the sample, and different size particles diffract the light at different angles to produce a particle size distribution [3].
Scanning electron microscopy (SEM)
Electron micrographs of PXM, spray dried PXM, GLU, spray dried GLU and all the spray dried solid dispersion in the various ratios were obtained using a scanning electron microscope (Jeol JSM-6060CV SEM) operating at 10 kV. The samples were mounted on a metal stub with double-sided adhesive tape and were sputter-coated with using a Quorum SC7620 Sputter Coater under vacuum with gold in an argon atmosphere prior to observation. Micrographs with different magnifications of 500x, 100x, 3000x and 5000x were taken to facilitate the study of the morphology of the solid dispersions.
Differential scanning calorimetry (DSC)
Samples of spray-dried solid dispersions or PM of drug:carrier (3 -6 mg) were placed in standard aluminium pans (40 µL) with a vented lid. The crimped aluminium pans were heated from 20 to 250 °C at a scanning rate of 10 °C/min using nitrogen gas as a purge gas in a DSC 1 (MettlerToledo, Switzerland). The enthalpy, onset temperatures and melting points of the samples were obtained using the STAR e thermal analysis software.
X-ray powder diffraction (XRPD)
The untreated PXM, GLU and PXM-GLU solid dispersions were characterised by X-ray powder diffraction (XRPD) according to the methodology reported by Laity et al 2015 [50] using a D2
Phaser diffractometer (Bruker AXS GmbH, Karlsruhe, Germany), with a sealed microfocus generator operated at 30 kV and 10 mA, producing Cu Ka (λ X = 0.1542 nm) radiation and a Lynxeye 'silicon strip' multi-angle detector. The samples were scanned in Bragg-Brantano geometry, over a scattering (Bragg, 2θ) angle range from 5 to 100°, in 0.02° steps at 1.5° min − 1 .
The XRPD patterns of were obtained using a Bruker D2 Phaser XRPD diffractometer. The samples were scanned from 5° to 10° 2  at a rate of 1.5° min −1 .
Solubility studies
Excess amount of the powder formulations were added to glass vials containing 10 mL of buffer (pH 1.2). The vials were sealed and placed into a Wise Bath WSB-18, where they were agitated at 37 °C ± 0.5 °C for 48 h. The solutions were then filtered using a 0.45 m membrane filter (Whatman, UK) and the filtrates were diluted with buffer (pH 1.2) before the absorbance of these solutions were measured using a UV spectrophotometer (UV-160, Shimadzu, Nakagyo, Japan) at 333 nm. The drug concentration in the samples was determined by applying a calibration curve which had a correlation coefficient of 1. The effects of GLU on the solubility of PXM were also investigated and this was achieved by the addition of an excess of PXM to 10 mL buffer (pH 1.2)
containing GLU at 1, 5, 10 and 15 % w/v.
Dissolution studies
USP dissolution apparatus I (DT700, ERWEKA, Heusenstamm, Germany) was used to monitor the dissolution profiles of PXM, PXM-GLU PMs and spray-dried solid dispersions. All formulations for the dissolution process contained the same amount of PXM (20 mg of PXM content was used regardless of the carrier quantity). The powder samples, after weighing, were introduced into the dissolution basket. Circular paper discs were used to cover the base of the baskets. This was to prevent the drug powder falling through the bottom pores. The dissolution medium was at pH 1. using a peristaltic pump. The concentrations of PXM in the samples were determined by UV spectrophotometer at 333 nm. All dissolution tests were carried out in triplicate.
Dissolution parameters
As an independent metric, the mean percentage of drug dissolved in the first 10 min (Q 10min ) and 30 min (Q 30min ) were used to represent the dissolution rate from various preparations. The dissolution efficiency (DE) of a pharmaceutical dosage form is defined as the area under the dissolution curve up to the time, t, expressed as the percentage of the area of the rectangle [51] as detailed elsewhere [52, 53] .
where y is the percentage of drug dissolved at time t.
Another approach to obtain a parameter that describes the dissolution rate is the mean dissolution time (MDT). This parameter is the most likely time taken for a molecule to be dissolved from a solid dosage form. In other words, MDT is the mean time for the drug to dissolve under in vitro dissolution conditions and is calculated using the following equation:
where j is the sample number, t j is the midpoint of the jth time period (calculated with ((t + t-1) /2) and M j is the additional amount of drug dissolved between t j and t-1.
The mean dissolution rate (MDR) can be calculated according to the following equations:
where n is the number of dissolution sample times, t is the time at the midpoint between t and t-1 (easily calculated with [t + (t-1)/2].
Similarity factor
Similarity between the drug release profiles was determined using similarity factor f 2 according to the equation below [54-57]
where n is the number of pull points for tested samples; is the optional weight factor; is the reference assay at time point t; is the test assay at time point t.
Similarity factor was calculated using the drug release profile of the untreated piroxicam as the reference. 
Triboelectric assessment of spray dried solid dispersions
The charge properties of powders were analysed using a recent novel approach developed at the in the Wolfson Centre at the University of Greenwich. In brief, a triboelectric device electrostatic inductive sensor was used to investigate the triboelectrification of powders under investigation [48] .
Such novel method allows the detection and measurement of charge distribution on the charge sign basis in a population of particles. The experimental apparatus consists of a single non-contact electrostatic inductive sensor (probe), a charge amplifier unit, a national instrument (NI) data acquisition equipment and personal computer for data recording and processing. A sample of each powder was fed in the cylindrical sensor with the help of vibratory feeder and conveyed toward the sensor by gravity in a vertical direction. Special care was taken by considering the adhesion property of particles with the wall of the sensor. After each experiment, the inner tube was replaced in order to remove any deposits, impurities or surface charge that may have been present on the surface from a previous test. A fresh sample was used for each test experiment. Each sample was analysed six times (humidity and temperature controlled laboratory: 50% RH, 22 ºC). A typical example of processed charge signal obtained as a result of the untreated PXM particles moving through the sensor using vibratory orifice feeder under gravity is shown in Figure 1b . The direction of each peak shows the polarity of charged particles and amplitude from baseline and represents the amount of charge on moving particle. The positive charge is the sum of positive charges whereas the negative charge is the sum of negative charges. The net charge is the sum of positive charges and negative charges. The charge-to-mass ratio (CMR or charge density) was defined as the charge (negative charge for N-CMR, positive charge for P-CMR, net charge for net-CMR) per unit mass, in nC/g.
RESULTS AND DISCUSSION
Untreated PXM showed a DE of only 21.2 % over the 120 min interval (Table 1) demonstrating the reported poor solubility of PXM, which in turn affects its bioavailability. PXM is a drug administered via the oral route and it will have to pass through the first pass metabolic pathway, which further lowers its bioavailability. In order to achieve the desired therapeutic effect a high dose of the drug will have to be administered [22] . The poor dissolution characteristics of PXM may be due to poor wettability, where the dissolution media is unable to spread efficiently over the solid surfaces to bring about dissolution [29] . In addition, agglomeration of the drug particles could also limit solubility. The results from the spray-dried PXM and PMs indicated no significant difference in PXM dissolution regardless of PXM:GLU ratio ( Figure 2a , Table 1 ) . In order words, the dissolution of the spray-dried PXM and the PM over the 120 min interval was similar to that of the untreated PXM (f2 = 74-93). However, when the untreated PXM was mixed with spray-dried GLU in the ratios 1:1, 1:2 and 2:1 (Figure 2b (Table 1 ). This may be due to the increased content of PXM in the formulation.
Generally, fine particulates tend to charge negatively, whereas large particles tend to charge positively. Lacks and Levandovsky, 2007 [60] provided a hypothetical mechanism for particle size dependent charging. Assuming that the surface density of trapped electrons is initially the same on all particles, it has been argued that the collisions allow electrons trapped in high-energy states on one particle to transfer to the vacant low-energy states on another particle. This has been recently discussed in a review [61] . Triboelectric charge analyses showed that all materials investigated demonstrated bipolar charge behaviour, i.e., contained both electropositive and electronegative charge particles. Untreated PXM showed an overall electronegative charge density (net-CMR = -3.8 ± 0.9 nC/g) (Figure 4a ). Such charging may result in several problems attributed to particle agglomeration, segregation and/or material adhesion on the processing equipment. In contrast, untreated GLU showed a very slight tendency towards electropositive charge (net-CMR = 0.5 ± 0.4 nC/g) ( Figure 4b ). As seen in Figures 4a and b , PXM demonstrated a considerably higher absolute charge than GLU carrier. This may be due to differences in the inherent charging properties between PXM and GLU as well as the small size of PXM in comparison to GLU (Supplementary   materials table 1) as it is known that electrostatic forces increase when particle size is decreased [16] . Both the electronegative charge density of PXM and the electropositive charge density of GLU increased following spray drying (~ 2.0 fold-increase in the case of PXM drug ~ 5.9 foldincrease in the case of GLU carrier) (Figures 4a, b) . Triboelectric charge analyses showed spray dried PXM:GLU solid dispersions to have considerably lower charge density (-0.1 ± 0.1 -0.3 ± 0.4 nC/g, p > 0.05) than untreated PXM (-3.8 ± 0.9 nC/g) and untreated GLU (0.5 ± 0.4 nC/g) ( Figure   5a ). This shows the spray drying method applied reduced the charge of pure PXM and thus improves powder handling. Figure 5b shows the dissolution of spray-dried PXM and GLU (samples A -C) and the results show an enhancement in dissolution as compared to the untreated PXM. The increase in dissolution of the spray dried solid dispersion samples is likely due to the formation of small particle sizes, increased surface area and potentially reduced inter-particle cohesive forces as indicated by a net charge density of less than 0.4 nC/g (Figure 5a ). SEM images (Figure 3 and supplementary materials table 1) showed the appearance of the spray-dried samples to be very different from that of the parent drug and carrier. The spray drying process yielded spherical particles of around 2.5 µm but showed some agglomeration in Sample A, B and C with sample B showing some of the needle-like characteristics of PXM form II [62] . The needle form of PXM may have contributed to the poor dissolution of sample B as it has been reported that the form II PXM polymorph is less soluble than the Form I polymorph [63] . However, this was in contrast to the observations by other researchers who report an increase in solubility with the Form II polymorph [64, 65] . This contrasting difference may be due to differences in in the preparation method as well as the contribution of the polymorphic form to the solubility. Lai et al. [65] reasoned that the cavitation forces as well as the collision and shear forces during the homogenising they conducted determines the breakdown of drug particles to the nanometre range. They deduced further that these high energetic forces can also induce a change in the crystal structure and/or partial or total amorphisation of the sample, which could cause further enhancement in solubility [66] .
The dissolution results suggest that when PXM and GLU were spray-dried together, the 2:1 ratio (sample C) was the best in achieving the optimum level of dissolution enhancement. Sample C increased the dissolution of PXM by over 30 % in comparison to untreated PXM. Samples A -C (DE 120min of 31-57 %) all had improved dissolution efficiency over that of the untreated PXM (DE 120min of 21 %).
With regards to solubility, Table 2 that solubility could be improved by increasing the proportion of GLU in the solutions. However, the same conclusion could not be made regarding the results from the dissolution test as there was no correlation (Table 1) . Al-Hamidi et al 2010 [3] concluded that an improvement in dissolution rate cannot be correlated to solubility and that parameters such as particle size, type of polymorph and hydrophobicity of particle surfaces are responsible for enhancement in dissolution. 
CONCLUSIONS
This study showed that spray-drying PXM alone was not sufficient to enhance the dissolution or solubility of PXM. This may be attributed to increased cohesive forces between spray dried PXM particles as compared to untreated PXM due to increased level of electrostatic charge. However, in the presence of a carrier such as GLU, spray drying proved to be effective at enhancing dissolution, therefore demonstrating glucosamine to be an efficient hydrophilic carrier for this process. This may be due to the relatively lack of cohesive electrostatic charge for spray dried solid dispersion particles allowing better particle wettability during dissolution. The PXM underwent some polymorphic changes during the spray drying process and this was confirmed by the SEM images and DSC traces. The dissolution rate of PXM in the solid dispersions could be optimised by varying the drug:carrier ratio to achieve the desired rate. The charge results also proved GLU to improve the handling of PXM as it significantly reduced its charge in all the spray dried formulations.
ACKNOWLEDGEMENTS
Figure captions 
